We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
-1.65%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.51B
AUM Growth
-$59.4M
Cap. Flow
+$92.2M
Cap. Flow %
6.09%
Top 10 Hldgs %
50.09%
Holding
339
New
32
Increased
81
Reduced
57
Closed
39

Top Buys

Rank Stock Value
1
CIH
China Index Holdings Limited American Depository Shares
CIH
+$10.8M
2
ABBV icon
AbbVie
ABBV
+$7.55M
3
QTT
Qutoutiao Inc. American Depositary Shares
QTT
+$4.66M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$3.3M
5
ARRY
Array Biopharma Inc
ARRY
+$3.22M

Top Sells

Rank Stock Value
1
BZUN
Baozun
BZUN
+$20.3M
2
DBRG icon
DigitalBridge
DBRG
+$14.9M
3
BKD icon
Brookdale Senior Living
BKD
+$12.7M
4
VIPS icon
Vipshop
VIPS
+$8.37M
5
CMTA
Clementia Pharmaceuticals Inc.
CMTA
+$6.37M

Sector Composition

Rank Sector Weight
1 Healthcare 31.82%
2 Financials 5.48%
3 Industrials 3.38%
4 Technology 2.61%
5 Communication Services 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
51
Bristol-Myers Squibb
BMY
$128B
$3.74M 0.25%
83,000
– –
LJPC
52
DELISTED
La Jolla Pharmaceutical Company
LJPC
$3.74M 0.25%
416,260
– –
MSFT icon
53
Microsoft
MSFT
$2.89T
$3.52M 0.23%
26,230
-95
-0.4% -$12.1K
IMMU
54
DELISTED
Immunomedics Inc
IMMU
$3.47M 0.23%
250,433
+15,000
+6% +$226K
TGA
55
DELISTED
Transglobe Energy Corp
TGA
$3.38M 0.22%
2,422,923
– –
BABA icon
56
Alibaba
BABA
$276B
$3.36M 0.22%
19,710
-3,070
-13% -$530K
RARE icon
57
Ultragenyx Pharmaceutical
RARE
$2.65B
$3.36M 0.22%
54,144
+8,000
+17% +$509K
CERS icon
58
Cerus
CERS
$615M
$3.31M 0.22%
669,245
+170,707
+34% +$944K
MDCO
59
DELISTED
Medicines Co
MDCO
$3.29M 0.22%
92,500
+50,000
+118% +$1.63M
OXFD
60
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$3.27M 0.22%
237,783
– –
STML
61
DELISTED
Stemline Therapeutics, Inc.
STML
$3.21M 0.21%
212,936
-55,000
-21% -$796K
ARCC icon
62
Ares Capital
ARCC
$13.6B
$3.17M 0.21%
178,707
– –
HRTX icon
63
Heron Therapeutics
HRTX
$86.9M
$3.16M 0.21%
171,557
+106,000
+162% +$2.12M
RARX
64
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$3.1M 0.2%
108,073
– –
BRK.B icon
65
Berkshire Hathaway Class B
BRK.B
$1.07T
$3.07M 0.2%
14,500
-1,300
-8% -$269K
AGIO icon
66
Agios Pharmaceuticals
AGIO
$2.2B
$3.06M 0.2%
+61,652
New +$3.3M
MDT icon
67
Medtronic
MDT
$108B
$3.04M 0.2%
31,190
+1,390
+5% +$127K
DRNA
68
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.97M 0.2%
188,673
– –
TBPH icon
69
Theravance Biopharma
TBPH
$874M
$2.97M 0.2%
185,899
+81,434
+78% +$1.65M
QTT
70
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$2.9M 0.19%
+73,507
New +$4.66M
DCPH
71
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2.89M 0.19%
128,037
– –
CTSH icon
72
Cognizant
CTSH
$22.3B
$2.83M 0.19%
44,850
-1,400
-3% -$91.9K
MO icon
73
Altria Group
MO
$122B
$2.77M 0.18%
57,780
+11,433
+25% +$599K
PGNX
74
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$2.75M 0.18%
472,580
– –
ALDR
75
DELISTED
Alder Biopharmaceuticals
ALDR
$2.64M 0.17%
233,858
– –
1 2
3
4 5

Similar funds

NC
NovaPoint Capital Atlanta, Georgia $399M AUM 26.97% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
IAA
Ironsides Asset Advisors Rocky Mount, North Carolina $399M AUM 13.99% 1-Year Est. Return
PNFS
PW Nova Financial Services Newtown, Pennsylvania $399M AUM
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return

Fosun International's Q2 2019 Portfolio in Review

As of Q2 2019, Fosun International held 339 positions worth $1.51B, down 3.8% from $1.57B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Fosun International deployed $92.2M of net new capital in Q2 2019, opening 32 new positions and adding to 81 existing holdings. Its largest new stake was China Index Holdings Limited American Depository Shares: 3,186,499 shares worth $11.3M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was DigitalBridge, an estimated $14.9M trimmed.

  • Fosun International's largest Q2 2019 buy was China Index Holdings Limited American Depository Shares: 3,186,499 shares worth $11.3M.
  • Fosun International added most to Array Biopharma Inc in Q2 2019, an estimated $3.22M increase.
  • Fosun International's biggest Q2 2019 reduction was DigitalBridge, cutting an estimated $14.9M.
  • Fosun International fully exited Baozun in Q2 2019, selling an estimated $20.3M.
  • Fosun International's ten largest holdings make up 50% of its $1.51B portfolio in Q2 2019.
  • Fosun International opened 32 new positions and closed 39 in Q2 2019.
  • Fosun International's portfolio value fell 3.8% quarter-over-quarter to $1.51B.

Based on Fosun International's 13F filing for Q2 2019, filed 12 Aug 2019.